Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Barbara Ann Karmanos Cancer Institute
Emory University
Children's Oncology Group
Children's Oncology Group
University of Chicago
National Cancer Institute (NCI)